TuHURA Biosciences, Inc.
HURA
$2.62
-$0.04-1.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 2.44M | 1.72M | 783.50K | 1.02M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 7.02M | 5.69M | 3.73M | 4.61M | |
| Operating Income | -7.02M | -5.69M | -3.73M | -4.61M | |
| Income Before Tax | -6.66M | -6.00M | -5.58M | -4.84M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -6.66M | -6.00M | -5.58M | -4.84M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -6.66M | -6.00M | -5.58M | -4.84M | |
| EBIT | -7.02M | -5.69M | -3.73M | -4.61M | |
| EBITDA | -7.00M | -5.68M | -3.70M | -4.57M | |
| EPS Basic | -0.15 | -0.14 | -0.09 | -0.40 | |
| Normalized Basic EPS | -0.10 | -0.09 | -0.05 | -0.25 | |
| EPS Diluted | -0.15 | -0.14 | -0.09 | -0.40 | |
| Normalized Diluted EPS | -0.10 | -0.09 | -0.05 | -0.25 | |
| Average Basic Shares Outstanding | 43.40M | 42.32M | 76.37M | 12.17M | |
| Average Diluted Shares Outstanding | 43.40M | 42.32M | 76.37M | 12.17M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -0.03% | -- | -- | -- | |